Egyre.,célratörobb" lipidterápiás szokásaink-A Magyar MULTI GAP 2010 eredményei

Translated title of the contribution: Becoming more focused therapeutic lipid patterns: Results from the Hungarian MULTI GAP 2010

István Reiber, G. Paragh, László Márk, Gyula Pados

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Previous studies have found that many high-risk patients are not achieving their LDL-cholesterol goals, and many patients, despite being treated with lipid-lowering therapy, also have elevated triglycerides and/or low levels of HDL-cholesterol. Aims: Authors analyzed the treatment strategies for dyslipidemic subjects following cardiovascular events similarly to their former survey from 2008 and 2009. Methods: In the MULTI GAP (MULTI Goal Attainment Problem) 2010 trial data from standard and structured questionnaires of 2332 patients were processed. Authors analyzed the proportion of the patients reaching target levels for total cholesterol, LDL-C, HDL-C, A-C (atherogen cholesterol) and triglyceride. Results: 15% (n = 355) of the patients did not receive any lipid lowering treatment. 44% of the patients treated by specialists reached the target LDL-C level of 2.5 mmol/l. In.,high risk" group target levels for HDL-C were reached by 61% of the patients, and for triglyceride by 43% of the subjects. 43% of the patients with the best compliance (>90%) reached the target LDL-C level of 2.5 mmol/l. Conclusion: There is a need for more effective lipid lowering therapy with more frequent use of higher doses of statins or combinations of lipid lowering drugs.

Original languageHungarian
Pages (from-to)822-827
Number of pages6
JournalOrvosi Hetilap
Volume152
Issue number21
DOIs
Publication statusPublished - May 1 2011

Fingerprint

Lipids
Triglycerides
Therapeutics
LDL Cholesterol
Hydroxymethylglutaryl-CoA Reductase Inhibitors
HDL Cholesterol
Compliance
Cholesterol
Pharmaceutical Preparations
oxidized low density lipoprotein
Surveys and Questionnaires

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Egyre.,célratörobb" lipidterápiás szokásaink-A Magyar MULTI GAP 2010 eredményei. / Reiber, István; Paragh, G.; Márk, László; Pados, Gyula.

In: Orvosi Hetilap, Vol. 152, No. 21, 01.05.2011, p. 822-827.

Research output: Contribution to journalArticle

Reiber, István ; Paragh, G. ; Márk, László ; Pados, Gyula. / Egyre.,célratörobb" lipidterápiás szokásaink-A Magyar MULTI GAP 2010 eredményei. In: Orvosi Hetilap. 2011 ; Vol. 152, No. 21. pp. 822-827.
@article{c9353555515d4de48f50267d708ffea3,
title = "Egyre.,c{\'e}lrat{\"o}robb{"} lipidter{\'a}pi{\'a}s szok{\'a}saink-A Magyar MULTI GAP 2010 eredm{\'e}nyei",
abstract = "Previous studies have found that many high-risk patients are not achieving their LDL-cholesterol goals, and many patients, despite being treated with lipid-lowering therapy, also have elevated triglycerides and/or low levels of HDL-cholesterol. Aims: Authors analyzed the treatment strategies for dyslipidemic subjects following cardiovascular events similarly to their former survey from 2008 and 2009. Methods: In the MULTI GAP (MULTI Goal Attainment Problem) 2010 trial data from standard and structured questionnaires of 2332 patients were processed. Authors analyzed the proportion of the patients reaching target levels for total cholesterol, LDL-C, HDL-C, A-C (atherogen cholesterol) and triglyceride. Results: 15{\%} (n = 355) of the patients did not receive any lipid lowering treatment. 44{\%} of the patients treated by specialists reached the target LDL-C level of 2.5 mmol/l. In.,high risk{"} group target levels for HDL-C were reached by 61{\%} of the patients, and for triglyceride by 43{\%} of the subjects. 43{\%} of the patients with the best compliance (>90{\%}) reached the target LDL-C level of 2.5 mmol/l. Conclusion: There is a need for more effective lipid lowering therapy with more frequent use of higher doses of statins or combinations of lipid lowering drugs.",
keywords = "combination therapy, HDL-C, LDL-C, residual risk, statins, target levels, triglyceride",
author = "Istv{\'a}n Reiber and G. Paragh and L{\'a}szl{\'o} M{\'a}rk and Gyula Pados",
year = "2011",
month = "5",
day = "1",
doi = "10.1556/OH.2011.29127",
language = "Hungarian",
volume = "152",
pages = "822--827",
journal = "Orvosi Hetilap",
issn = "0030-6002",
publisher = "Akademiai Kiado",
number = "21",

}

TY - JOUR

T1 - Egyre.,célratörobb" lipidterápiás szokásaink-A Magyar MULTI GAP 2010 eredményei

AU - Reiber, István

AU - Paragh, G.

AU - Márk, László

AU - Pados, Gyula

PY - 2011/5/1

Y1 - 2011/5/1

N2 - Previous studies have found that many high-risk patients are not achieving their LDL-cholesterol goals, and many patients, despite being treated with lipid-lowering therapy, also have elevated triglycerides and/or low levels of HDL-cholesterol. Aims: Authors analyzed the treatment strategies for dyslipidemic subjects following cardiovascular events similarly to their former survey from 2008 and 2009. Methods: In the MULTI GAP (MULTI Goal Attainment Problem) 2010 trial data from standard and structured questionnaires of 2332 patients were processed. Authors analyzed the proportion of the patients reaching target levels for total cholesterol, LDL-C, HDL-C, A-C (atherogen cholesterol) and triglyceride. Results: 15% (n = 355) of the patients did not receive any lipid lowering treatment. 44% of the patients treated by specialists reached the target LDL-C level of 2.5 mmol/l. In.,high risk" group target levels for HDL-C were reached by 61% of the patients, and for triglyceride by 43% of the subjects. 43% of the patients with the best compliance (>90%) reached the target LDL-C level of 2.5 mmol/l. Conclusion: There is a need for more effective lipid lowering therapy with more frequent use of higher doses of statins or combinations of lipid lowering drugs.

AB - Previous studies have found that many high-risk patients are not achieving their LDL-cholesterol goals, and many patients, despite being treated with lipid-lowering therapy, also have elevated triglycerides and/or low levels of HDL-cholesterol. Aims: Authors analyzed the treatment strategies for dyslipidemic subjects following cardiovascular events similarly to their former survey from 2008 and 2009. Methods: In the MULTI GAP (MULTI Goal Attainment Problem) 2010 trial data from standard and structured questionnaires of 2332 patients were processed. Authors analyzed the proportion of the patients reaching target levels for total cholesterol, LDL-C, HDL-C, A-C (atherogen cholesterol) and triglyceride. Results: 15% (n = 355) of the patients did not receive any lipid lowering treatment. 44% of the patients treated by specialists reached the target LDL-C level of 2.5 mmol/l. In.,high risk" group target levels for HDL-C were reached by 61% of the patients, and for triglyceride by 43% of the subjects. 43% of the patients with the best compliance (>90%) reached the target LDL-C level of 2.5 mmol/l. Conclusion: There is a need for more effective lipid lowering therapy with more frequent use of higher doses of statins or combinations of lipid lowering drugs.

KW - combination therapy

KW - HDL-C

KW - LDL-C

KW - residual risk

KW - statins

KW - target levels

KW - triglyceride

UR - http://www.scopus.com/inward/record.url?scp=79955807725&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79955807725&partnerID=8YFLogxK

U2 - 10.1556/OH.2011.29127

DO - 10.1556/OH.2011.29127

M3 - Article

VL - 152

SP - 822

EP - 827

JO - Orvosi Hetilap

JF - Orvosi Hetilap

SN - 0030-6002

IS - 21

ER -